FDC
|
The Current P/B Ratio of FDC is 2.83.
| Share Price | ₹431.9 | Jul 09,2026 |
| Market Cap | ₹7,030.5 Cr | |
| Book Value | ₹2,485.1 Cr | Mar2026 - Consolidated Results |
| Price/Book | 2.83x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of FDC
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹7,030.5 Cr] as on Jul 09,2026
(/) Book Value [ ₹2,485.1 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 2.83x ]
Thus, for FDC , the investors are currently willing to pay '2.83 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of FDC !
The chart below summarizes the trend in P/B Ratio of FDC over the last five years.
Historical PB (Price/Book ) ratio chart of FDC
PB Ratio Performance Analysis for FDC
- FDC 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.65x.
- FDC 's operated at median p/b ratio of 2.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/b ratio peaked in Mar2024 at 3.3x.
- FDC 's p/b ratio hit its five-year low in Mar2023 of 2.15x.
How does FDC 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| FDC | 2,485.11 | 2.83 | 7,030.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.57 | 465,195.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 10.79 | 180,823.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 19.76 | 165,725.0 |
| CIPLA LTD | 34,369.40 | 3.39 | 116,467.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.81 | 105,987.0 |
| MANKIND PHARMA LTD | 16,300.30 | 6.41 | 104,544.0 |
| LUPIN LTD | 22,448.30 | 5.10 | 114,441.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.27 | 115,695.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.41 | 91,283.7 |
| LAURUS LABS LTD | 5,275.08 | 15.40 | 81,210.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs FDC 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.41x |
| Max industry PB | 19.76x |
| Median industry PB | 5.10x |
| Average industry PB | 7.16x |
You may also like the below Video Courses